welcome
Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Business

Business & Economics

Tonix Pharmaceuticals Corp. (Nasdaq:TNXP) ranks 7th on our list of stocks that fall behind amid market optimism

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
Summary
Nutrition label

67% Informative

Tonix Pharmaceuticals Corp. (NASDAQ: TNXP ) fell by 9.64 percent on Wednesday to finish at $ 17.91 apiece.

The recent sell-off signaled investor pessimism, shunning its recent partnership with Makana Therapeutics .

Overall, TNXP ranks 7th on our list of stocks that fall behind amid market optimism.

VR Score

61

Informative language

62

Neutral language

44

Article tone

formal

Language

English

Language complexity

62

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.